Traditional Medicare vs. Medicare Advantage: How Your Plan Shapes Stroke Care

Most Americans who suffer a stroke are 65 or older, which means most stroke patients are enrolled in Medicare. What fewer patients or their families know is that the type of Medicare plan they hold - government-run traditional Medicare or privately administered Medicare Advantage - may shape nearly every dimension of their stroke care, from the preventive services they access beforehand to the rehabilitation they receive afterward.

A first-of-its-kind systematic analysis from UVA Health, published in the Journal of Comparative Effectiveness Research, examined seven published studies comparing stroke-related outcomes across the two plan types. The findings reveal a complex picture of trade-offs that cannot easily be summarized as one plan outperforming the other.

Two Plans, Two Payment Logics

Traditional Medicare operates on a fee-for-service model: the federal government pays healthcare providers for each service rendered, with no annual cap on covered services. Medicare Advantage, introduced to reduce costs through private-sector competition, works differently. The government pays private insurers a fixed amount per enrollee; the insurer then covers care within that budget. This creates financial incentives for Advantage plans to limit expensive services through mechanisms such as prior authorization requirements, restricted provider networks, and payment caps.

More than half of Medicare enrollees are now on Medicare Advantage. Despite the original cost-saving rationale, the Medicare Payment Advisory Commission estimated that government payments to Medicare Advantage plans in 2025 exceeded what traditional Medicare would have cost by approximately 20 percent, adding roughly $84 billion to federal healthcare expenditures.

Differences in Care Access and Recovery

The UVA analysis found that patients on traditional Medicare were less likely to access certain stroke-preventing care before their stroke events. Medicare Advantage patients, by contrast, had better access to programs addressing modifiable risk factors - smoking cessation, cholesterol management, blood pressure control - that reduce the likelihood of stroke in the first place.

After a stroke, the pattern reversed. Traditional Medicare patients were more likely to receive intensive post-stroke rehabilitation. Medicare Advantage patients faced higher rates of prior authorization hurdles for rehabilitation services, and the researchers attribute the lower rehabilitation rates among Advantage enrollees directly to these authorization requirements.

Despite receiving less post-stroke rehabilitation, Medicare Advantage patients reached recovery milestones more quickly than traditional Medicare patients. They were less likely to be rehospitalized after discharge and more likely to transition to assisted-living and community-living arrangements rather than remaining in institutional care settings. The researchers offer one possible explanation: Medicare Advantage enrollees may have been in better baseline health before their strokes, making recovery easier regardless of the care they received afterward.

Why Direct Comparisons Are Difficult

The analysis carries important caveats that the researchers themselves emphasize. The seven studies available for review varied in methodology, outcome definitions, and the time periods they covered. Direct comparison between traditional Medicare and Medicare Advantage populations is complicated by what epidemiologists call selection bias: people who choose Advantage plans tend to differ systematically from those who remain on traditional Medicare in ways that affect health outcomes independently of the plan itself.

Advantage enrollees may be healthier on average, more engaged with preventive care, and more likely to live in geographic areas with robust provider networks. Traditional Medicare populations may include more patients with complex comorbidities who specifically require unlimited access to services. Disentangling these baseline differences from the effects of the plans themselves requires more granular data than the available studies provide.

Lead researcher Jonathan R. Crowe, MD, MPH, MSc, a neurologist at UVA Health and the University of Virginia School of Medicine, described the data limitations as a key constraint on interpretation. A stroke registry linked to Medicare enrollment data would allow researchers to control for baseline health status and trace individual patients through both types of plans, generating the kind of evidence needed to make confident policy recommendations.

Stakes for an Aging Population

The policy context makes this research timely. Stroke is the fifth leading cause of death in the United States and a leading cause of long-term disability. As the U.S. population ages and Medicare enrollment grows, the question of how insurance plan structure affects stroke outcomes carries increasing weight for patients, clinicians, and policymakers navigating debates about healthcare costs and reform.

The UVA team, which included Emily J. Bian, Priyanka Menon, Kathleen A. McManus, Timothy J. Layton, Bradford B. Worrall, and Crowe, declared no financial interest in the work. The study is open access.